Evidence map›Paper›PMID 26031187›Full record

Trial reportAlcoholism, clinical and experimental research2015

Subgroup Identification in Personalized Treatment of Alcohol Dependence.

Jue Hou, Chamindi Seneviratne, Xiaogang Su, Jeremy Taylor, Bankole Johnson, Xin-Qun Wang, Heping Zhang, Henry R Kranzler, Joseph Kang, Lei Liu

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in Alcoholism, clinical and experimental research, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Article
  4. Review
  5. Article
  6. [Subgroup identification based on the Logistic model].Nan fang yi ke da xue xue bao = Journal of Southern Medical University · 2018
    Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Jue HouDepartment of Statistics, University of Illinois, Urbana, Illinois.
Chamindi SeneviratneDepartment of Psychiatry, Institute for Genome Sciences, University of Maryland, Baltimore, Maryland.
Xiaogang SuDepartment of Mathematical Sciences, University of Texas at El Paso (UTEP), El Paso, Texas.
Jeremy TaylorDepartment of Biostatistics, University of Michigan, Ann Arbor, Michigan.
Bankole JohnsonDepartment of Psychiatry, Institute for Genome Sciences, University of Maryland, Baltimore, Maryland.
Xin-Qun WangDepartment of Public Health Sciences, University of Virginia, Charlottesville, Virginia.
Heping ZhangDepartment of Biostatistics, Yale University, New Haven, Connecticut.
Henry R KranzlerDepartment of Psychiatry, University of Pennsylvania, Philadelphia, Pennsylvania.
Joseph KangDepartment of Preventive Medicine, Northwestern University, Chicago, Illinois.
Lei LiuDepartment of Preventive Medicine, Northwestern University, Chicago, Illinois.

Funding

Statistical Methods in Genetic Studies of Substance UseR01DA016750 · NIDA · YALE UNIVERSITY · PI ZHANG, HEPING · 2004 to 2016
$3.3M
NIDA NIH HHS R01 DA 016750NIDA NIH HHS R01 DA016750
6 · The paper itself

Abstract

backgroundIdentification of patient subgroups to enhance treatment effects is an important topic in personalized (or tailored) alcohol treatment. Recently, several recursive partitioning methods have been proposed to identify subgroups benefiting from treatment. These novel data mining methods help to address the limitations of traditional regression-based methods that focus on interactions.

methodsWe propose an exploratory approach, using recursive partitioning methods, for example, interaction trees (IT) and virtual twins (VT), to flexibly identify subgroups in which the treatment effect is likely to be large. We apply these tree-based methods to a pharmacogenetic trial of ondansetron.

resultsOur methods identified several subgroups based on patients' genetic and other prognostic covariates. Among the 251 subjects with complete genotype information, the IT method identified 118 with specific genetic and other prognostic factors, resulting in a 17.2% decrease in the percentage of heavy drinking days (PHDD). The VT method identified 88 subjects with a 21.8% decrease in PHDD. Overall, the VT subgroup achieved a good balance between the treatment effect and the group size.

conclusionsA data mining approach is proposed as a valid exploratory method to identify a sufficiently large subgroup of subjects that is likely to receive benefit from treatment in an alcohol dependence pharmacotherapy trial. Our results provide new insights into the heterogeneous nature of alcohol dependence and could help clinicians to tailor treatment to the biological profile of individual patients, thereby achieving better treatment outcomes.

Indexed as

Precision MedicineAdultAgedAlcoholismHumansMiddle AgedOndansetronPharmacogeneticsSerotonin AntagonistsSerotonin Plasma Membrane Transport ProteinsYoung AdultOndansetronSerotonin AntagonistsSerotonin Plasma Membrane Transport ProteinsSLC6A4 protein, humanAlcohol ResearchClassification and Regression TreeClinical TrialRandom Forest

Identifiers

PMID26031187
PMCPMC4491003

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.